Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.72818 | 31 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.68303 | 30 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.68873 | 30 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.65566 | 31 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.6256 | 30 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.8334 | 33 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.6832 | 28 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.66448 | 30 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.68471 | 31 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.67617 | 30 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.67322 | 30 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.66115 | 30 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.67031 | 29 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.67747 | 30 |